FDA Inspection 1258225 — SETON PHARMACEUTICALS LLC
The FDA completed an inspection of SETON PHARMACEUTICALS LLC on Dec 12, 2024 in Wall, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 12, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Wall, NJ (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)